跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ipravent
Approved
STANDARD
Ipravent
Geofman Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5da856ccc1e1e2a8
Company
Geofman Pharmaceuticals
Type
Standard
Approval Details
Approval Id
5da856ccc1e1e2a8
Drug Approval Philippines Name
Ipravent
Product Name
Ipravent
Registration Number
DRP-5276
Brand Name
Ipravent
Generic Name
Ipratropium Bromide + Salbutamol (as Sulfate)
Dosage Form
Solution for Inhalation
Dosage Strength
200 mcg/ 1 mg per mL
Manufacturer
Geofman Pharmaceuticals
Importer
Sahar International Trading, Inc.
Distributor
Sahar International Trading, Inc.
Issuance Date
24 June 2022
Expiry Date
24 July 2027
Pharmacologic Category
Anticholinergic/Selective Beta-2-Adrenoreceptor Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5da856ccc1e1e2a8
Type
Standard
Back to Philippines FDA Approvals
Ipravent - Philippines FDA Drug Approval Details